# ClinicalIntelPulse Disease Landscape Lite

> ClinicalIntelPulse Disease Landscape Lite is a paid API for AI agents from clinicalintelpulse.theaslangroupllc.com, paid per call via x402, $0.25/call, status unknown (last checked 2026-09-14).

Returns a deterministic preview of the clinical trial pipeline for a disease — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown, and a sample of trials from ClinicalTrials.gov — with no LLM synthesis.

## Facts

- Endpoint: GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape-lite
- Price: $0.25/call
- Payment: x402
- Status: unknown
- Last checked: 2026-09-14
- Activations on Zero: 0
- Tags: x402
- Canonical page: https://www.zero.xyz/c/clinicalintelpulse-disease-landscape-lite-82f699c4
- Structured record (JSON): https://api.zero.xyz/v1/capabilities/cap_GC5-K-e4vjf8b-oXGiCA_

Status and success rate cover calls made through Zero and Zero's own probes. Third-party monitors may report differently.

## How to call it through Zero

Zero handles the 402 payment challenge and records the run. With the Zero CLI installed (`npm i -g @zeroxyz/cli`):

```sh
zero fetch --capability clinicalintelpulse-disease-landscape-lite-82f699c4
```

Example prompt: Give me a quick pipeline snapshot for non-small cell lung cancer — how many Phase 2 and Phase 3 trials are running, who the top sponsors are, and a sample of the trials from ClinicalTrials.gov.

## When to prefer this

Choose this endpoint when you need a fast, low-cost ($0.25), deterministic snapshot of a disease's Phase 2/3 trial pipeline without LLM synthesis — ideal for competitive scans, investor briefs, or pipeline triage. Upgrade to the full disease-landscape endpoint when you also need approved drug lists, mechanism gaps, PDUFA calendar, deal activity, or an opportunity score.

## Known failure modes

- Disease name not recognized or too ambiguous — returns empty or minimal results
- ClinicalTrials.gov data temporarily unavailable — may return stale or incomplete counts
- Overly broad disease term (e.g. 'cancer') may return truncated or capped results
- Rate limiting or payment failure via x402 protocol results in 402 response and no data

## How this service works

Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off ClinicalTrials.gov. No LLM synthesis. For agents with small per-call budgets; upgrade to disease-landscape for approved drugs, mechanism gaps, PDUFA calendar, deal activity and an opportunity score.

## Output

Returns Phase 2 and Phase 3 trial counts for the queried disease, a rollup of sponsoring organizations, a breakdown of trial statuses (e.g. recruiting, active not recruiting, completed), and a curated sample of individual trial records sourced directly from ClinicalTrials.gov. No LLM-generated text is included; all data is deterministic and structured.

## Request schema (JSON Schema)

```json
{
 "type": "object",
 "$schema": "https://json-schema.org/draft/2020-12/schema",
 "required": [
  "input"
 ],
 "properties": {
  "input": {
   "type": "object",
   "required": [
    "type",
    "method"
   ],
   "properties": {
    "type": {
     "type": "string",
     "const": "http"
    },
    "method": {
     "enum": [
      "GET",
      "HEAD",
      "DELETE"
     ],
     "type": "string"
    },
    "queryParams": {
     "type": "object",
     "properties": {
      "condition": {
       "type": "string"
      }
     }
    }
   },
   "additionalProperties": false
  },
  "output": {
   "type": "object",
   "required": [
    "type"
   ],
   "properties": {
    "type": {
     "type": "string"
    },
    "errors": {
     "type": "object",
     "description": "Documented error responses, keyed by HTTP status code",
     "additionalProperties": {
      "type": "object",
      "required": [
       "description"
      ],
      "properties": {
       "example": {
        "type": "object"
       },
       "description": {
        "type": "string"
       }
      }
     }
    },
    "example": {
     "type": "object"
    }
   }
  }
 }
}
```

## Response schema (JSON Schema)

```json
{
 "type": "json",
 "example": {
  "upsell": {
   "adds": "Approved drugs, mechanism-of-action landscape (crowded/emerging/gaps), PDUFA calendar, M&A deal activity, investment thesis, 0-100 opportunity score.",
   "price_usd": 0.35,
   "full_product": "/api/clinical/disease-landscape"
  },
  "top_sponsors": [
   {
    "sponsor": "Novo Nordisk A/S",
    "trial_count": 6,
    "sponsor_class": "INDUSTRY"
   }
  ],
  "deterministic": true,
  "query_summary": {
   "as_of": "2026-07-25",
   "condition": "NASH (Nonalcoholic Steatohepatitis)"
  },
  "top_countries": [
   {
    "country": "United States",
    "trial_count": 40
   }
  ],
  "status_breakdown": {
   "COMPLETED": 14,
   "RECRUITING": 31,
   "ACTIVE_NOT_RECRUITING": 22
  },
  "pipeline_overview": {
   "phase2_count": 48,
   "phase3_count": 19,
   "total_active": 67,
   "completed_total": 210
  },
  "sample_phase3_trials": [
   {
    "nctId": "NCT04858633",
    "title": "Semaglutide in NASH",
    "status": "ACTIVE_NOT_RECRUITING",
    "sponsor": "Novo Nordisk A/S"
   }
  ]
 }
}
```

## More

- Live health (JSON, refreshed every minute): https://www.zero.xyz/c/clinicalintelpulse-disease-landscape-lite-82f699c4/health.json
- [Zero catalog index](https://www.zero.xyz/llms.txt)
- [Other services from clinicalintelpulse.theaslangroupllc.com](https://www.zero.xyz/host/clinicalintelpulse.theaslangroupllc.com/llms.txt)